1. Home
  2. ULY vs SCNI Comparison

ULY vs SCNI Comparison

Compare ULY & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULY
  • SCNI
  • Stock Information
  • Founded
  • ULY 2013
  • SCNI 2003
  • Country
  • ULY United States
  • SCNI Israel
  • Employees
  • ULY N/A
  • SCNI N/A
  • Industry
  • ULY
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ULY
  • SCNI Health Care
  • Exchange
  • ULY Nasdaq
  • SCNI Nasdaq
  • Market Cap
  • ULY 4.0M
  • SCNI 4.6M
  • IPO Year
  • ULY N/A
  • SCNI N/A
  • Fundamental
  • Price
  • ULY $1.80
  • SCNI $1.02
  • Analyst Decision
  • ULY Strong Buy
  • SCNI
  • Analyst Count
  • ULY 2
  • SCNI 0
  • Target Price
  • ULY $11.50
  • SCNI N/A
  • AVG Volume (30 Days)
  • ULY 22.4K
  • SCNI 47.1K
  • Earning Date
  • ULY 11-12-2025
  • SCNI 11-24-2025
  • Dividend Yield
  • ULY N/A
  • SCNI N/A
  • EPS Growth
  • ULY N/A
  • SCNI N/A
  • EPS
  • ULY N/A
  • SCNI 0.26
  • Revenue
  • ULY $127,932,000.00
  • SCNI $1,147,000.00
  • Revenue This Year
  • ULY N/A
  • SCNI N/A
  • Revenue Next Year
  • ULY $20.23
  • SCNI N/A
  • P/E Ratio
  • ULY N/A
  • SCNI $3.55
  • Revenue Growth
  • ULY N/A
  • SCNI 303.87
  • 52 Week Low
  • ULY $1.74
  • SCNI $0.86
  • 52 Week High
  • ULY $17.99
  • SCNI $6.18
  • Technical
  • Relative Strength Index (RSI)
  • ULY 24.02
  • SCNI 44.44
  • Support Level
  • ULY $1.74
  • SCNI $0.88
  • Resistance Level
  • ULY $2.74
  • SCNI $0.95
  • Average True Range (ATR)
  • ULY 0.14
  • SCNI 0.08
  • MACD
  • ULY -0.03
  • SCNI 0.00
  • Stochastic Oscillator
  • ULY 5.00
  • SCNI 66.67

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: